Business Description
Medplus Health Services Ltd
ISIN : INE804L01022
Total Employee Number:
25,007Compare
Compare
Traded in other countries / regions
543427.India IPO Date
2021-12-23Description
Medplus Health Services Ltd and its subsidiaries are mainly engaged in the retail trading of medicines and general merchandise; wholesale cash-and-carry operations; the provision of diagnostic, pathological, and laboratory testing services; and the wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods, and beauty products. The Group's product portfolio includes essential items such as medications, vitamins, medical devices, home and personal care products, toiletries, baby care essentials, soaps, detergents, as well as sanitizers, among others. These products are mainly sold through a network of retail stores spread across India. The Group's reportable segments are: Retail, which generates maximum revenue, Diagnostics, and Others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.72 | |||||
Debt-to-EBITDA | 2.08 | |||||
Interest Coverage | 2.49 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.98 | |||||
Beneish M-Score | -1.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.6 | |||||
3-Year EBITDA Growth Rate | 29.4 | |||||
3-Year EPS without NRI Growth Rate | 65.9 | |||||
3-Year Book Growth Rate | 9.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.57 | |||||
9-Day RSI | 35.43 | |||||
14-Day RSI | 33.15 | |||||
3-1 Month Momentum % | -7.74 | |||||
6-1 Month Momentum % | -5.84 | |||||
12-1 Month Momentum % | -2.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3 | |||||
Quick Ratio | 1 | |||||
Cash Ratio | 0.86 | |||||
Days Inventory | 90.9 | |||||
Days Sales Outstanding | 0.83 | |||||
Days Payable | 21.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -1.39 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 25.8 | |||||
Operating Margin % | 4.35 | |||||
Net Margin % | 2.91 | |||||
EBITDA Margin % | 9.49 | |||||
FCF Margin % | 5.15 | |||||
OCF Margin % | 6.86 | |||||
ROE % | 11.35 | |||||
ROA % | 5.81 | |||||
ROIC % | 9.26 | |||||
3-Year ROIIC % | 24.15 | |||||
ROC (Joel Greenblatt) % | 16.96 | |||||
ROCE % | 13.14 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 39.97 | |||||
Forward PE Ratio | 37.21 | |||||
PE Ratio without NRI | 39.97 | |||||
Price-to-Owner-Earnings | 28.75 | |||||
PEG Ratio | 1.82 | |||||
PS Ratio | 1.16 | |||||
PB Ratio | 4.25 | |||||
Price-to-Tangible-Book | 4.36 | |||||
Price-to-Free-Cash-Flow | 22.57 | |||||
Price-to-Operating-Cash-Flow | 16.97 | |||||
EV-to-EBIT | 45.17 | |||||
EV-to-Forward-EBIT | 29.57 | |||||
EV-to-EBITDA | 25.74 | |||||
EV-to-Forward-EBITDA | 16.17 | |||||
EV-to-Revenue | 2.44 | |||||
EV-to-Forward-Revenue | 1.14 | |||||
EV-to-FCF | 47.39 | |||||
Price-to-GF-Value | 0.73 | |||||
Price-to-Projected-FCF | 2.57 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.69 | |||||
Price-to-Graham-Number | 2.72 | |||||
| Price-to-Net-Current-Asset-Value | 75.37 | |||||
Earnings Yield (Greenblatt) % | 2.21 | |||||
FCF Yield % | 2.21 | |||||
Forward Rate of Return (Yacktman) % | 21.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medplus Health Services Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 72,294.32 | ||
| EPS (TTM) (₹) | 17.52 | ||
| Beta | 0.0376 | ||
| 3-Year Sharpe Ratio | -0.52 | ||
| 3-Year Sortino Ratio | -0.69 | ||
| Volatility % | 23.3 | ||
| 14-Day RSI | 33.15 | ||
| 14-Day ATR (₹) | 23.579285 | ||
| 20-Day SMA (₹) | 739.9425 | ||
| 12-1 Month Momentum % | -2.47 | ||
| 52-Week Range (₹) | 653.8 - 1020.35 | ||
| Shares Outstanding (Mil) | 240.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medplus Health Services Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medplus Health Services Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2027 | 2027-02-02 16:00 | In 178 days | ||
| Third quarter earnings results for 2027 | 2027-02-02 | In 177 days | ||
| Second quarter earnings conference call for 2027 | 2026-11-03 16:00 | In 87 days | ||
| Second quarter earnings results for 2027 | 2026-11-03 | In 86 days | ||
| General meeting for 2026 | 2026-08-17 15:30 | In 9 days | ||
| Annual report for 2026 | 2026-07-23 | 695.05 (-2.99%) | ||
| First quarter earnings conference call for 2027 | 2026-07-22 16:00 | 795.40 (-1.64%) | ||
| First quarter earnings results for 2027 | 2026-07-22 | 795.40 (-1.64%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-21 16:00 | 934.00 (-0.66%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-21 | 934.00 (-0.66%) |
Show
Entries
Medplus Health Services Ltd Frequently Asked Questions
What is Medplus Health Services Ltd(BOM:543427)'s stock price today?
The current price of BOM:543427 is ₹700.20. The 52 week high of BOM:543427 is ₹1020.35 and 52 week low is ₹653.80.
When is next earnings date of Medplus Health Services Ltd(BOM:543427)?
The next earnings date of Medplus Health Services Ltd(BOM:543427) is 2026-11-03 Est..
Does Medplus Health Services Ltd(BOM:543427) pay dividends? If so, how much?
Medplus Health Services Ltd(BOM:543427) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medplus Health Services Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers